Colgate-Palmolive Company (NYSE:CL) is included among the 13 Best Dividend Kings to Buy in 2026. On January 16, Barclays ...
Wells Fargo upgrades Colgate-Palmolive (CL) to Equal Weight, citing improved valuation but ongoing volume/pricing headwinds.
With consumer staples stocks out of favor, Colgate-Palmolive's share price slumped in 2025. The company has accelerated its product development pace. Colgate-Palmolive has met or exceeded its organic ...
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $87.77, with a ...
Colgate-Palmolive stock (NYSE: CL) has gained 40% in value since early January 2023 – jumping from levels of around $75 then to over $105 now – vs. an increase of about 45% for the S&P 500 over this ...
Colgate-Palmolive Colgate-Palmolive (NYSE: CL) reported its Q1 results on April 26, with revenues and earnings above the street estimates. The company reported $5.1 billion revenue and $0.86 adjusted ...
Colgate-Palmolive (CL) is a Dividend King with strong dividend safety, high margins, and consistent long-term execution, currently trading at a reasonable 21.6x earnings. CL’s science-based innovation ...
Toothpaste and toothbrush giant Colgate-Palmolive hit a full-year revenue milestone in 2024 Colgate-Palmolive Co. shares are down 4.9% Friday despite the toothpaste and toothbrush giant reporting ...
Hosted on MSN
Piper Sandler Initiates Coverage of Colgate-Palmolive (CL) with Overweight Recommendation
Fintel reports that on September 24, 2024, Piper Sandler initiated coverage of Colgate-Palmolive (NYSE:CL) with a Overweight recommendation. Analyst Price Forecast Suggests 4.20% Upside As of August ...
NEW YORK--(BUSINESS WIRE)-- Colgate-Palmolive Company (NYSE:CL) today announced several executive leadership appointments that will take effect June 16, 2025. Shane Grant, 50, will join ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results